Ahn-Gook Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Ahn-Gook Pharmaceutical has a total shareholder equity of ₩165.6B and total debt of ₩77.3B, which brings its debt-to-equity ratio to 46.7%. Its total assets and total liabilities are ₩303.2B and ₩137.6B respectively. Ahn-Gook Pharmaceutical's EBIT is ₩6.1B making its interest coverage ratio 3.6. It has cash and short-term investments of ₩32.6B.
Key information
46.7%
Debt to equity ratio
₩77.30b
Debt
| Interest coverage ratio | 3.6x |
| Cash | ₩32.58b |
| Equity | ₩165.55b |
| Total liabilities | ₩137.63b |
| Total assets | ₩303.18b |
Recent financial health updates
Recent updates
Statutory Earnings May Not Be The Best Way To Understand Ahn-Gook Pharmaceutical's (KOSDAQ:001540) True Position
Aug 26
Pinning Down Ahn-Gook Pharmaceutical Co., Ltd.'s (KOSDAQ:001540) P/E Is Difficult Right Now
Aug 13Are Dividend Investors Making A Mistake With Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)?
Apr 02Ahn-Gook Pharmaceutical (KOSDAQ:001540) Shareholders Booked A 29% Gain In The Last Year
Mar 07Is Ahn-Gook Pharmaceutical (KOSDAQ:001540) Using Too Much Debt?
Feb 14Do Insiders Own Lots Of Shares In Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)?
Jan 19Dividend Investors: Don't Be Too Quick To Buy Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540) For Its Upcoming Dividend
Dec 24A Look At The Fair Value Of Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
Dec 10Key Things To Consider Before Buying Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540) For Its Dividend
Nov 18
Financial Position Analysis
Short Term Liabilities: A001540's short term assets (₩135.3B) exceed its short term liabilities (₩77.6B).
Long Term Liabilities: A001540's short term assets (₩135.3B) exceed its long term liabilities (₩60.0B).
Debt to Equity History and Analysis
Debt Level: A001540's net debt to equity ratio (27%) is considered satisfactory.
Reducing Debt: A001540's debt to equity ratio has increased from 19.1% to 46.7% over the past 5 years.
Debt Coverage: A001540's debt is not well covered by operating cash flow (9.5%).
Interest Coverage: A001540's interest payments on its debt are well covered by EBIT (3.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 15:28 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ahn-Gook Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Min-young Lee | Korea Investment & Securities Co., Ltd. |